Development of a multiplex MethyLight assay for the detection of multigene methylation in human colorectal cancer

Cancer Genetics and Cytogenetics

Volumn 202, Issue 1, 2010, Pages 1-10

  He, Qiong ^a   Chen, Hua Yun ^b   Bai, En Qi ^b   Luo, Yan Xin ^c   Fu, Rui Jia ^b   He, Yun Shao ^b   Jiang, Jie ^b   Wang, Hua Qiao ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY   (China)

^c THE SIXTH AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARISTALESS LIKE HOMEOBOX 4 PROTEIN; BIOLOGICAL MARKER; PROTEIN; SEPTIN 9; TRANSMEMBRANE PROTEIN WITH EGF LIKE AND TWO FOLLISTATIN LIKE DOMAIN 2; UNCLASSIFIED DRUG; ALX4 PROTEIN, HUMAN; CYTOSKELETON PROTEIN; DNA; DNA BINDING PROTEIN; GUANINE NUCLEOTIDE BINDING PROTEIN; MEMBRANE PROTEIN; PRIMER DNA; SEPT9 PROTEIN, HUMAN; SEPTIN; TMEFF2 PROTEIN, HUMAN; TRANSCRIPTION FACTOR; TUMOR PROTEIN;

ADULT; AGED; ARTICLE; ASSAY; BLOOD EXAMINATION; BLOOD SAMPLING; CANCER DIAGNOSIS; CANCER PATIENT; CANCER TISSUE; COLORECTAL CANCER; CONTROLLED STUDY; DNA METHYLATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MULTIPLEX POLYMERASE CHAIN REACTION; NON INVASIVE MEASUREMENT; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SCREENING; SENSITIVITY AND SPECIFICITY; BLOOD; COLORECTAL TUMOR; GENETICS; ISOLATION AND PURIFICATION; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PROCEDURES; REFERENCE VALUE; TUMOR CELL LINE;

BASE SEQUENCE; CELL LINE, TUMOR; COLORECTAL NEOPLASMS; CYTOSKELETAL PROTEINS; DNA METHYLATION; DNA PRIMERS; DNA, NEOPLASM; DNA-BINDING PROTEINS; GTP-BINDING PROTEINS; HUMANS; MEMBRANE PROTEINS; MOLECULAR SEQUENCE DATA; NEOPLASM PROTEINS; POLYMERASE CHAIN REACTION; REFERENCE VALUES; SEPTINS; TRANSCRIPTION FACTORS;

EID: 77956143206     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2010.05.018     Document Type: Article

References (28)

1. Jemal A., Thomas A., Murray T., Thun M. Cancer statistics, 2002. CA Cancer J Clin 2002, 52:23-47. [Erratum in: CA Cancer J Clin 2002;52:119; and in CA Cancer J Clin 2002;52:181-182].
2. Zheng S., Cai S.R. Colorectal cancer epidemiology and prevention study in China. Chin Ger J Clin Oncol 2003, 2:72-75.
3. Winawer S.J., Zauber A.G., Ho M.N., O'Brien M.J., Gottlieb L.S., Sternberg S.S., et al. The National Polyp Study Workgroup. Prevention of colorectal cancer by colonoscopic polypectomy. N Engl J Med 1993, 329:1977-1981.
4. Kondo Y., Issa J.P. Epigenetic changes in colorectal cancer. Cancer Metastasis Rev 2004, 23:29-39.
5. Iacopetta B., Grieu F., Phillips M., Ruszkiewicz A., Moore J., Minamoto T., et al. Methylation levels of LINE-1 repeats and CpG island loci are inversely related in normal colonic mucosa. Cancer Sci 2007, 98:1454-1460.
6. Shen L., Issa J.P. Epigenetics in colorectal cancer. Curr Opin Gastroenterol 2002, 18:68-73.
7. Lecomte T., Berger A., Zinzindohoue F., Micard S., Landi B., Blons H., et al. Detection of free-circulating tumor-associated DNA in plasma of colorectal cancer patients and its association with prognosis. Int J Cancer 2002, 100:542-548.
8. INK4A promoter methylation in plasma of patients with colorectal cancer and its association with prognosis: results of a 3-year GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study. Ann Oncol 2006, 17(Suppl. 7):84-90. vii.
9. Urakami S., Shiina H., Enokida H., Hirata H., Kawamoto K., Kawakami T., et al. Wnt antagonist family genes as biomarkers for diagnosis, staging, and prognosis of renal cell carcinoma using tumor and serum DNA. Clin Cancer Res 2006, 12:6989-6997.
10. Wong I.H., Lo Y.M., Zhang J., Liew C.T., Ng M.H., Wong N., et al. Detection of aberrant p16 methylation in the plasma and serum of liver cancer patients. Cancer Res 1999, 59:71-73.
11. Sabbioni S., Miotto E., Veronese A., Sattin E., Gramantieri L., Bolondi L., et al. Multigene methylation analysis of gastrointestinal tumors: TPEF emerges as a frequent tumor-specific aberrantly methylated marker that can be detected in peripheral blood. Mol Diagn 2003, 7:201-207.
12. Grutzmann R., Molnar B., Pilarsky C., Habermann J.K., Schlag P.M., Saeger H.D., et al. Sensitive detection of colorectal cancer in peripheral blood by septin 9 DNA methylation assay. PLoS One 2008, 3:e3759.
13. Ebert M.P., Model F., Mooney S., Hale K., Lograsso J., Tonnes-Priddy L., et al. Aristaless-like homeobox-4 gene methylation is a potential marker for colorectal adenocarcinomas. Gastroenterology 2006, 131:1418-1430.
14. Leung W.K., To K.F., Man E.P., Chan M.W., Bai A.H., Hui A.J., et al. Quantitative detection of promoter hypermethylation in multiple genes in the serum of patients with colorectal cancer. Am J Gastroenterol 2005, 100:2274-2279.
15. Zou H., Harrington J.J., Shire A.M., Rego R.L., Wang L., Campbell M.E., et al. Highly methylated genes in colorectal neoplasia: implications for screening. Cancer Epidemiol Biomarkers Prev 2007, 16:2686-2696.
16. Worm J., Aggerholm A., Guldberg P. In-tube DNA methylation profiling by fluorescence melting curve analysis. Clin Chem 2001, 47:1183-1189.
17. INK4A methylation in sera of patients with liver cirrhosis and hepatocellular carcinoma. J Korean Med Sci 2004, 19:83-86.
18. Lofton-Day C., Model F., Devos T., Tetzner R., Distler J., Schuster M., et al. DNA methylation biomarkers for blood-based colorectal cancer screening. Clin Chem 2008, 54:414-423.
19. Model F., Osborn N., Ahlquist D., Gruetzmann R., Molnar B., Sipos F., et al. Identification and validation of colorectal neoplasia-specific methylation markers for accurate classification of disease. Mol Cancer Res 2007, 5:153-163.
20. Young J., Biden K.G., Simms L.A., Huggard P., Karamatic R., Eyre H.J., et al. HPP1: a transmembrane protein-encoding gene commonly methylated in colorectal polyps and cancers. Proc Natl Acad Sci U S A 2001, 98:265-270.
21. Suzuki M., Shigematsu H., Shames D.S., Sunaga N., Takahashi T., Shivapurkar N., et al. DNA methylation-associated inactivation of TGFβ-related genes DRM/Gremlin, RUNX3, and HPP1 in human cancers. Br J Cancer 2005, 93:1029-1037.
22. Russell S.E., Hall P.A. Do septins have a role in cancer?. Br J Cancer 2005, 93:499-503.
23. deVos T., Tetzner R., Model F., Weiss G., Schuster M., Distler J., et al. Circulating methylated SEPT9 DNA in plasma is a biomarker for colorectal cancer. Clin Chem 2009, 55:1337-1346.
24. Eads C.A., Danenberg K.D., Kawakami K., Saltz L.B., Blake C., Shibata D., et al. MethyLight: a high-throughput assay to measure DNA methylation. Nucleic Acids Res 2000, 28:E32.
25. Grunau C., Clark S.J., Rosenthal A. Bisulfite genomic sequencing: systematic investigation of critical experimental parameters. Nucleic Acids Res 2001, 29. E65-5.
26. Fackler M.J., McVeigh M., Mehrotra J., Blum M.A., Lange J., Lapides A., et al. Quantitative multiplex methylation-specific PCR assay for the detection of promoter hypermethylation in multiple genes in breast cancer. Cancer Res 2004, 64:4442-4452.
27. Eads C.A., Lord R.V., Kurumboor S.K., Wickramasinghe K., Skinner M.L., Long T.I., et al. Fields of aberrant CpG island hypermethylation in Barrett's esophagus and associated adenocarcinoma. Cancer Res 2000, 60:5021-5026.
28. Mandel J.S., Church T.R., Ederer F., Bond J.H. Colorectal cancer mortality: effectiveness of biennial screening for fecal occult blood. J Natl Cancer Inst 1999, 91:434-437.